Toggle menu
Toggle preferences menu
Toggle personal menu
Not logged in
Your IP address will be publicly visible if you make any edits.

Cyproheptadine: Difference between revisions

From Pharmacopedia
[unchecked revision][checked revision]
Auto-created stub
 
parser-claude: Cyproheptadine MedTemplate refill, Top 300 stub upgrade
 
(5 intermediate revisions by the same user not shown)
Line 1: Line 1:
{{MedTemplate
{{MedTemplate
| generic          = Cyproheptadine
| generic          = Cyproheptadine (hydrochloride)
| brand            = Periactin
| brand            = Periactin (US brand discontinued; generic widely available)
| classes          = Antihistamine
| structure        =
| mechanism        = H1 and 5-HT2 receptor antagonist
| classes          = [[:Category:Antihistamines|First-generation antihistamine]], [[:Category:Serotonin antagonists|Serotonin 5-HT2 antagonist]], [[:Category:Orexigenics|Appetite-promoting medicine (orexigenic)]]
| uses              = <vote slug="allergic-conditions-use">Allergic conditions including urticaria and seasonal allergies (FDA)</vote>, <vote slug="serotonin-syndrome-antidote-use">Serotonin syndrome (off-label; the standard pharmacological antidote alongside supportive care and benzodiazepines)</vote>, <vote slug="appetite-stimulation-cachexia-use">Appetite stimulation in failure to thrive, cachexia, and anorexia (off-label, evidence-supported in pediatric and adult populations)</vote>, <vote slug="migraine-prophylaxis-pediatric-use">Pediatric migraine prophylaxis (off-label)</vote>, <vote slug="ssri-sexual-dysfunction-adjunct-use">SSRI-induced sexual dysfunction (off-label adjunct, modest evidence)</vote>
| starting_dose    = Allergy: 4 mg PO TID. Serotonin syndrome: 12 mg loading dose PO or by nasogastric tube, then 2 mg every 2 hours until clinical improvement. Appetite stimulation: 2-4 mg PO TID-QID
| preparations      = Tablets 4 mg; oral syrup 2 mg/5 mL
| fda_max          = 32 mg/day adult; weight-based pediatric ceiling
| pill_id          =
| routes            = Oral
| onset            = 30-60 minutes
| duration          = 6-8 hours
| halflife          = 8-16 hours<ref name="periactin-label">FDA Prescribing Information, Periactin (cyproheptadine hydrochloride), Merck/various, current revision. https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/010407s058lbl.pdf</ref>
| bioavailability  = ~95% (oral)<ref name="periactin-label" />
| pregnancy        = Limited human data; older agent with substantial use experience.{{citation needed}}
| legal            = [[USLegal:Prescription only|Rx-only]] in US
| mechanism        = <vote slug="cyproheptadine-mech-claim">First-generation H1 histamine receptor antagonist with substantial additional '''5-HT2A and 5-HT2C serotonin receptor antagonism'''. The 5-HT2A antagonism is the basis of its role as the first-line pharmacological antidote for serotonin syndrome; the 5-HT2C antagonism underlies the appetite stimulation effect (the same receptor mechanism that drives weight gain with mirtazapine and olanzapine).</vote> Anticholinergic and sedating, with the standard first-generation antihistamine Beers-list concerns in elderly patients<ref name="periactin-label" />.
}}
}}
== References ==
<references />
[[Category:Antihistamines]]
[[Category:Antihistamines]]
 
[[Category:Serotonin antagonists]]
[[Category:Orexigenics]]